Caspase-1 Variants and Plasma IL-1β in Patients with Leishmania guyanensis Cutaneous Leishmaniasis in the Amazonas

Josué Lacerda de Souza,Marcus Vinitius de Farias Guerra,Tirza Gabrielle Ramos de Mesquita,José do Espírito Santo Junior,Hector David Graterol Sequera,Lener Santos da Silva,Larissa Almeida da Silva,Filipe Menezes Moura,Lizandra Stephanny Fernandes Menescal,Júlia da Costa Torres,Suzana Kanawati Pinheiro,Herllon Karllos Athaydes Kerr,Mauricio Morishi Ogusku,Mara Lúcia Gomes de Souza,Jose Pereira de Moura Neto,Aya Sadahiro,Rajendranath Ramasawmy
DOI: https://doi.org/10.3390/ijms252212438
IF: 5.6
2024-11-24
International Journal of Molecular Sciences
Abstract:Leishmaniasis, a disease caused by protozoan Leishmania spp., exhibits a broad range of clinical manifestations. Host resistance or susceptibility to infections is often influenced by the genetic make-up associated with natural immunity. Caspase-1, a key component of the NLRP3 inflammasome, is critical for processing pro-IL-1β into its active form, IL-1β, while CARD8 functions as an NLRP3 inflammasome inhibitor. We conducted a case–control study comparing L. guyanensis-cutaneous leishmaniasis (Lg-CL) patients with healthy individuals (HCs) by analyzing the CASP1 genetic variants rs530537A>G, rs531542C>T, rs531604A>T and rs560880G>T. Additionally, a combined analysis of CARD8rs2043211A>T with CASP1rs530537 was performed. The genotype distribution for the four variants showed no significant differences between Lg-CL patients and HCs. However, the haplotype analysis of the four CASP1 variants identified the GTTT haplotype as associated with a 19% decreased likelihood of Lg-CL development, suggesting a protective effect against disease progression. The combined analysis of CARD8 with CASP1 variants indicated that individuals homozygous for both variants (GG/TT) exhibited a 38% reduced risk of developing Lg-CL (OR = 0.62 [95%CI:0.46–0.83]) in comparison to individuals with other genotype combinations. No correlation was found between the CASP1 variant genotypes and plasma IL-1β levels. CASP1 may act as a genetic modifier in Lg-CL.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?